Department of Molecular Carcinogenesis, Medical University of Lodz, 90-752, Lodz, Poland.
BMC Med Genomics. 2020 Nov 19;13(1):174. doi: 10.1186/s12920-020-00823-9.
Among all causes of death, cancer is the most prevalent and is only outpaced by cardiovascular diseases. Molecular theory of carcinogenesis states that apoptosis and proliferation are regulated by groups of tumor suppressors or oncogenes. Transcription factors are example of proteins comprising representatives of both cancer-related groups. Exemplary family of transcription factors which exhibits dualism of function is Activating enhancer-binding Protein 2 (AP-2). Scientific reports concerning their function in carcinogenesis depend on particular family member and/or tumor type which proves the issue to be unsolved. Therefore, the present study examines role of the best-described AP-2 representatives, AP-2α and AP-2γ, through ontological analysis of their target genes and investigation what processes are differentially regulated in 21 cancers using samples deposited in Genomic Data Analysis Center (GDAC) Firehose.
Expression data with clinical annotation was collected from TCGA-dedicated repository GDAC Firehose. Transcription factor targets were obtained from Gene Transcription Regulation Database (GTRD), TRANScription FACtor database (TRANSFAC) and Transcriptional Regulatory Relationships Unraveled by Sentence-based Text mining (TRRUST). Monocle3 R package was used for global samples profiling while Protein ANalysis THrough Evolutionary Relationships (PANTHER) tool was used to perform gene ontology analysis.
With RNA-seq data and Monocle3 or PANTHER tools we outlined differences in many processes and signaling pathways, separating tumor from normal tissues or tumors from each other. Unexpectedly, a number of alterations in basal-like breast cancer were identified that distinguished it from other subtypes, which could bring future clinical benefits.
Our findings indicate that while the AP-2α/γ role remains ambiguous, their activity is based on processes that underlie the cancer hallmarks and their expression could have potential in diagnosis of selected tumors.
在所有死因中,癌症最为普遍,仅次于心血管疾病。致癌的分子理论表明,凋亡和增殖受肿瘤抑制因子或癌基因群的调节。转录因子是包含癌症相关两组代表的蛋白质的示例。激活增强子结合蛋白 2(AP-2)是具有功能二元性的转录因子的典范家族。关于它们在致癌作用中的功能的科学报告取决于特定的家族成员和/或肿瘤类型,这证明该问题尚未解决。因此,本研究通过对其靶基因的本体论分析以及使用 Genomic Data Analysis Center (GDAC) Firehose 中存储的样本调查 21 种癌症中哪些过程受到差异调节,来研究最佳描述的 AP-2 代表物 AP-2α 和 AP-2γ 的作用。
从 TCGA 专用存储库 GDAC Firehose 收集具有临床注释的表达数据。从 Gene Transcription Regulation Database(GTRD),TRANScription FACtor database(TRANSFAC)和 Transcriptional Regulatory Relationships Unraveled by Sentence-based Text mining(TRRUST)获得转录因子靶标。使用 Monocle3 R 软件包对全局样本进行分析,而使用 Protein ANalysis THrough Evolutionary Relationships(PANTHER)工具进行基因本体分析。
使用 RNA-seq 数据和 Monocle3 或 PANTHER 工具,我们概述了许多过程和信号通路的差异,将肿瘤与正常组织或肿瘤彼此分开。出乎意料的是,确定了基底样乳腺癌的许多改变,这些改变将其与其他亚型区分开来,这可能为未来的临床带来益处。
我们的发现表明,尽管 AP-2α/γ 的作用仍然不确定,但它们的活性基于构成癌症特征的过程,并且它们的表达可能对某些肿瘤的诊断具有潜在价值。